In silico modeling of asthma

Area of Science:

• Pulmonary Medicine
• Computational Biology
• Pharmacology

Background:

• Asthma incidence is rising globally, particularly in children, posing a significant public health concern.
• Current pharmacologic treatments and clinical protocols exist, but targeted aerosol delivery could enhance inhaled medicine efficacy.
• Understanding disease-induced airway morphological changes is crucial for optimizing drug delivery.

Purpose of the Study:

• To develop a mathematical model of asthma's effects on airway morphology.
• To integrate this model with a computer code simulating inhaled drug behavior and deposition.
• To validate the in silico model against experimental data from human subjects.

Main Methods:

• Developed a morphological algorithm defining asthma-induced airway heterogeneity.
• Integrated the algorithm into a computational code for inhaled drug fate simulation.
• Compared model-predicted drug particle deposition patterns with SPECT imaging data from healthy and asthmatic individuals.

Main Results:

• Simulations from the asthma drug delivery model demonstrated agreement with human testing observations.
• The in silico model successfully predicted drug particle deposition patterns in airways.
• Validation against SPECT images confirmed the model's accuracy in representing asthmatic conditions.

Conclusions:

• In silico modeling offers a robust technical foundation for analyzing disease effects on aerosolized drug administration.
• The developed model supports the targeted delivery of inhaled medicines for improved asthma treatment.
• Modeling should be considered a complementary tool in future inhalation therapy protocols.